Page 29 - Testing Solutions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ortho's VITROS SARS-CoV-2 Antigen Test for Accurate, Mass-Scale COVID-19 Testing is the First High-Volume Test to Receive FDA Emergency Use Authorization i, clinically reliable results on Ortho's high-volume VITROS Systems, which are installed in over 5,600 laboratories around the world. More than 1,500 VITROS analyzers are operational across the U.S. - including more than 500 located in rural regions, where coronavirus testing needs are especially urgent. These analyzers normally run a broad menu of over 150 different tests from blood and body fluid samples, but now are also able to run sa...

Share this article Below is the updated press release. Beckman Coulter Launches one of the First High-Quality, High-Throughput COVID-19 Antigen Test Ideal for Mass Testing in the U.S. The Access SARS-CoV-2 Antigen assay is offered to healthcare providers at $4, making reliable and frequent mass testing affordable Assay's limit of detection is 2 to 200 times lower therefore more sensitive than most point-of-care (POC) antigen tests Test runs on Beckman Coulter's analyzers capable of processing up to 200 samples per hour, enabling high throughput screening in just 30 minutes and addressing the ...

Share this article Below is the updated press release. Beckman Coulter Launches one of the First High-Quality, High-Throughput COVID-19 Antigen Test Ideal for Mass Testing in the U.S. The Access SARS-CoV-2 Antigen assay is offered to healthcare providers at $4, making reliable and frequent mass testing affordable Assay's limit of detection is 2 to 200 times lower therefore more sensitive than most point-of-care (POC) antigen tests Test runs on Beckman Coulter's analyzers capable of processing up to 200 samples per hour, enabling high throughput screening in just 30 minutes and addressing the ...